118 related articles for article (PubMed ID: 32404579)
1. The Endocytic Mechanism and Cytotoxicity of Boron-Containing Vesicles.
Wang D; Meng Y; Wang X; Xia G; Zhang Q
Chem Pharm Bull (Tokyo); 2020 Jul; 68(7):618-627. PubMed ID: 32404579
[TBL] [Abstract][Full Text] [Related]
2. One stone kills three birds: novel boron-containing vesicles for potential BNCT, controlled drug release, and diagnostic imaging.
Chen G; Yang J; Lu G; Liu PC; Chen Q; Xie Z; Wu C
Mol Pharm; 2014 Oct; 11(10):3291-9. PubMed ID: 24521224
[TBL] [Abstract][Full Text] [Related]
3. Tracing Boron with Fluorescence and Positron Emission Tomography Imaging of Boronated Porphyrin Nanocomplex for Imaging-Guided Boron Neutron Capture Therapy.
Shi Y; Li J; Zhang Z; Duan D; Zhang Z; Liu H; Liu T; Liu Z
ACS Appl Mater Interfaces; 2018 Dec; 10(50):43387-43395. PubMed ID: 30451482
[TBL] [Abstract][Full Text] [Related]
4. Rational design of gold nanoparticles functionalized with carboranes for application in Boron Neutron Capture Therapy.
Ciani L; Bortolussi S; Postuma I; Cansolino L; Ferrari C; Panza L; Altieri S; Ristori S
Int J Pharm; 2013 Dec; 458(2):340-6. PubMed ID: 24140178
[TBL] [Abstract][Full Text] [Related]
5. Novel Self-Forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and Its Molecular Glue Effect.
Fithroni AB; Kobayashi K; Uji H; Ishimoto M; Akehi M; Ohtsuki T; Matsuura E
Cells; 2022 Oct; 11(20):. PubMed ID: 36291173
[TBL] [Abstract][Full Text] [Related]
6. Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT).
Wu CY; Lin JJ; Chang WY; Hsieh CY; Wu CC; Chen HS; Hsu HJ; Yang AS; Hsu MH; Kuo WY
Colloids Surf B Biointerfaces; 2019 Nov; 183():110387. PubMed ID: 31394419
[TBL] [Abstract][Full Text] [Related]
7. Selective endocytic trafficking in live cells with fluorescent naphthoxazoles and their boron complexes.
Dias GG; Rodrigues BL; Resende JM; Calado HD; de Simone CA; Silva VH; Neto BA; Goulart MO; Ferreira FR; Meira AS; Pessoa C; Correa JR; da Silva Júnior EN
Chem Commun (Camb); 2015 Jun; 51(44):9141-4. PubMed ID: 25943956
[TBL] [Abstract][Full Text] [Related]
8. Amphiphilic Polycarbonates from Carborane-Installed Cyclic Carbonates as Potential Agents for Boron Neutron Capture Therapy.
Xiong H; Wei X; Zhou D; Qi Y; Xie Z; Chen X; Jing X; Huang Y
Bioconjug Chem; 2016 Sep; 27(9):2214-23. PubMed ID: 27548011
[TBL] [Abstract][Full Text] [Related]
9. A stable meta-carborane enables the generation of boron-rich peptide agonists targeting the ghrelin receptor.
Worm DJ; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Koebberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
J Pept Sci; 2018 Oct; 24(10):e3119. PubMed ID: 30168238
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of boron containing monosaccharides by the hydroboration of d-glucal for use in boron neutron capture therapy (BNCT).
Itoh T; Tamura K; Ueda H; Tanaka T; Sato K; Kuroda R; Aoki S
Bioorg Med Chem; 2018 Dec; 26(22):5922-5933. PubMed ID: 30420329
[TBL] [Abstract][Full Text] [Related]
11. Trivalent galactosyl-functionalized mesoporous silica nanoparticles as a target-specific delivery system for boron neutron capture therapy.
Lai CH; Lai NC; Chuang YJ; Chou FI; Yang CM; Lin CC
Nanoscale; 2013 Oct; 5(19):9412-8. PubMed ID: 23958787
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
13. Intracellular delivery and passive tumor targeting of a self-assembled nanogel containing carborane clusters for boron neutron capture therapy.
Kawasaki R; Sasaki Y; Akiyoshi K
Biochem Biophys Res Commun; 2017 Jan; 483(1):147-152. PubMed ID: 28039054
[TBL] [Abstract][Full Text] [Related]
14. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
15. Hydrophobic boron compound-loaded poly(l-lactide-co-glycolide) nanoparticles for boron neutron capture therapy.
Takeuchi I; Nomura K; Makino K
Colloids Surf B Biointerfaces; 2017 Nov; 159():360-365. PubMed ID: 28806667
[TBL] [Abstract][Full Text] [Related]
16. Enlargement of a Modular System-Synthesis and Characterization of an
Kellert M; Lönnecke P; Riedl B; Koebberling J; Hey-Hawkins E
Molecules; 2019 Sep; 24(18):. PubMed ID: 31509949
[TBL] [Abstract][Full Text] [Related]
17. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
Iguchi Y; Michiue H; Kitamatsu M; Hayashi Y; Takenaka F; Nishiki T; Matsui H
Biomaterials; 2015 Jul; 56():10-7. PubMed ID: 25934274
[TBL] [Abstract][Full Text] [Related]
19. Brucella intracellular replication requires trafficking through the late endosomal/lysosomal compartment.
Starr T; Ng TW; Wehrly TD; Knodler LA; Celli J
Traffic; 2008 May; 9(5):678-94. PubMed ID: 18266913
[TBL] [Abstract][Full Text] [Related]
20. Polyborane-encapsulated PEGylated Liposomes Prepared Using Post-insertion Technique for Boron Neutron Capture Therapy.
Takeuchi I; Kanno Y; Uchiro H; Makino K
J Oleo Sci; 2019; 68(12):1261-1270. PubMed ID: 31787674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
